VPC-18005

Names

[ Name ]:
VPC-18005

[Synonym ]:
{2-[(2E)-2-(4-Isopropylbenzylidene)hydrazino]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}acetic acid
2-(2-{(Z)-2-[(E)-(4-isopropylphenyl)methylidene]hydrazono}-4-oxo-1,3-thiazolan-5-yl)acetic acid
5-Thiazoleacetic acid, 4,5-dihydro-2-[(2E)-2-[[4-(1-methylethyl)phenyl]methylene]hydrazinyl]-4-oxo-
MFCD00758307
MFCD28248832

Biological Activity

[Description]:

VPC-18005 (VPC18005) is a novel small molecule ERG (ETS-related gene) antagonist that inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain, disrupts the ERG binding to DNA (Kd=250 uM); markedly decreases SOX9 expression, inhibits migration and invasion of ERG-overexpressing prostate cancer cells in vitro, and reduces metastasis in a zebrafish xenograft model.

[References]

References 1. Butler MS, et al. Oncotarget. 2017 Jun 27;8(26):42438-42454. View Related Products by Target Other Targets

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
506.3±52.0 °C at 760 mmHg

[ Molecular Formula ]:
C₁₅H₁₇N₃O₃S

[ Molecular Weight ]:
319.379

[ Flash Point ]:
260.0±30.7 °C

[ Exact Mass ]:
319.099060

[ LogP ]:
2.72

[ Vapour Pressure ]:
0.0±1.4 mmHg at 25°C

[ Index of Refraction ]:
1.647

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.